.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Farmers Insurance
US Army
Accenture
Moodys
McKesson
Chinese Patent Office
Covington
Fuji

Generated: November 24, 2017

DrugPatentWatch Database Preview

Ortho Mcneil Company Profile

« Back to Dashboard

What is the competitive landscape for ORTHO MCNEIL, and what generic alternatives to ORTHO MCNEIL drugs are available?

ORTHO MCNEIL has thirty-eight approved drugs.

There are ten US patents protecting ORTHO MCNEIL drugs.

There are one hundred and fifty-eight patent family members on ORTHO MCNEIL drugs in thirty countries and thirty-four supplementary protection certificates in eleven countries.

Summary for Ortho Mcneil

International Patents:158
US Patents:10
Tradenames:42
Ingredients:22
NDAs:38
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm
TYLENOL W/ CODEINE
acetaminophen; codeine phosphate
SOLUTION;ORAL085057-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000DISCNNoNo► Subscribe► Subscribe ► Subscribe
Ortho Mcneil Pharm
ORTHO-NOVUM 7/14-28
ethinyl estradiol; norethindrone
TABLET;ORAL-28019004-002Apr 4, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
TYLENOL W/ CODEINE NO. 4
acetaminophen; codeine phosphate
CAPSULE;ORAL087421-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
THEOPHYL-SR
theophylline
CAPSULE, EXTENDED RELEASE;ORAL086471-001Feb 8, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
NORCEPT-E 1/35 21
ethinyl estradiol; norethindrone
TABLET;ORAL-21071545-001Feb 9, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol lactate
CONCENTRATE;ORAL015922-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
DIENESTROL
dienestrol
CREAM;VAGINAL006110-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Janssen
TOLECTIN
tolmetin sodium
TABLET;ORAL017628-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Janssen
TOLECTIN 600
tolmetin sodium
TABLET;ORAL017628-002Mar 8, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ortho Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil Pharm
FLOXIN IN DEXTROSE 5%
ofloxacin
INJECTABLE;INJECTION020087-001Mar 31, 1992► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil Pharm
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
ofloxacin
INJECTABLE;INJECTION020087-005Mar 31, 1992► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil Pharm
FLOXIN
ofloxacin
INJECTABLE;INJECTION020087-003Mar 31, 1992► Subscribe► Subscribe
Ortho Mcneil Janssen
TOLECTIN
tolmetin sodium
TABLET;ORAL017628-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Ortho Mcneil

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,261,584 Sustained delivery of an active agent using an implantable system► Subscribe
8,080,259Sustained delivery of an active agent using an implantable system► Subscribe
8,298,562Sustained delivery of an active agent using an implantable system► Subscribe
8,535,701Sustained delivery of an active agent using an implantable system► Subscribe
7,655,257Sustained delivery of an active agent using an implantable system► Subscribe
6,635,268 Sustained delivery of an active agent using an implantable system► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ortho Mcneil Drugs

Country Document Number Estimated Expiration
South Africa9700831► Subscribe
Malaysia128850► Subscribe
Japan2001527035► Subscribe
Colombia4761076► Subscribe
Spain2378675► Subscribe
Norway983544► Subscribe
Portugal1736145► Subscribe
Israel156090► Subscribe
European Patent Office1041974► Subscribe
Czech Republic300994► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Ortho Mcneil Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0005Belgium► SubscribePRODUCT NAME: ESTRADIOL HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: 298 IS 190 F 15 19960806; FIRST REGISTRATION: GB PL/0053/0241 19950711
/2004Austria► SubscribePRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211
C0040Belgium► SubscribePRODUCT NAME: ALATROFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/060/001 19980327; FIRST REGISTRATION: CH 54484 19980327
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0022France► SubscribePRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211
00221Netherlands► SubscribePRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0003Belgium► SubscribePRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
C/GB09/026United Kingdom► SubscribePRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Mallinckrodt
Baxter
Cipla
Fish and Richardson
Colorcon
Medtronic
McKinsey
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot